...
首页> 外文期刊>Cell death & disease. >MiR-22 suppresses epithelial–mesenchymal transition in bladder cancer by inhibiting Snail and MAPK1/Slug/vimentin feedback loop
【24h】

MiR-22 suppresses epithelial–mesenchymal transition in bladder cancer by inhibiting Snail and MAPK1/Slug/vimentin feedback loop

机译:MiR-22通过抑制蜗牛和MAPK1 / SLUI / Vimentin反馈回路抑制膀胱癌中的上皮 - 间充质转换

获取原文
           

摘要

MicroRNAs (miRNAs) have been validated to play prominent roles in the occurrence and development of bladder cancer (BCa). MiR-22 was previously reported to act as a tumor suppressor or oncomiRNA in various types of cancer. However, its accurate expression, function, and mechanism in BCa remain unclear. Here, we find that miR-22 is frequently downregulated in BCa tissues compared with adjacent non-cancerous tissues. Overexpression of miR-22 significantly inhibits proliferation, migration, and invasion of BCa cells both in vitro and in vivo. Importantly, miR-22 is found to suppress cell proliferation/apoptosis by directly targeting MAPK1 (mitogen-activated protein kinase 1, ERK2) and inhibit cell motility by targeting both MAPK1 and Snail. Further statistical analysis shows that low-expression of MAPK1 or Snail is an independent prognostic factor for a better overall survival in patients with BCa (n?=?401). Importantly, we describe an important regenerative feedback loop among vimentin, Slug and MAPK1 in BCa cells. MAPK1-induced Slug expression upregulates vimentin. Vimentin in turn activates MAPK1. By inhibiting Snail and MAPK1/Slug/vimentin feedback loop, miR-22 suppresses epithelial–mesenchymal transition (EMT) of BCa cells in vitro as well as in vivo. Taken together, this study reveals that miR-22 is critical to the proliferation, apoptosis and EMT progression in BCa cells. Targeting the pathway described here may be a novel approach for inhibiting proliferation and metastasis of BCa.
机译:Micrornas(MiRNA)已被验证以在膀胱癌(BCA)的发生和发展中起着突出的作用。先前据报道,miR-22以各种类型的癌症中的肿瘤抑制或oncomirna充当。然而,BCA中的精确表达,功能和机制仍然不清楚。在这里,与相邻的非癌组织相比,我们发现miR-22经常在BCA组织中下调。 miR-22的过度表达显着抑制了体外和体内BCA细胞的增殖,迁移和侵袭。重要的是,发现miR-22通过直接靶向MAPK1(丝裂剂活化的蛋白激酶1,ERK2)来抑制细胞增殖/凋亡并通过靶向MAPK1和蜗牛抑制细胞活性。进一步的统计分析表明,MAPK1或蜗牛的低表达是BCA患者更好地生存的独立预后因素(n?= 401)。重要的是,我们在BCA细胞中描述了Vimentin,SLUG和MAPK1中的重要再生反馈环。 MAPK1诱导的SLUIn表达上调uGimentates。 Vimentin反过来激活MAPK1。通过抑制蜗牛和MAPK1 / SLUG / Vimentin反馈回路,MiR-22在体外抑制BCA细胞的上皮 - 间充质转变(EMT)以及体内。在一起,本研究表明,MIR-22对BCA细胞的增殖,凋亡和EMT进展至关重要。靶向此处描述的途径可以是抑制BCA的增殖和转移的新方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号